Vol 12, No 3 (2010)
- Year: 2010
 - Published: 15.09.2010
 - Articles: 23
 - URL: https://modernonco.orscience.ru/1815-1434/issue/view/1478
 
Articles
Na territorii Rossiyskoy FederatsiiGertseptin zaregistrirovan v kachestve terapiirasprostranennoy adenokartsinomy zheludkaili pishchevodno-zheludochnogo perekhodas opukholevoy giperekspressiey HER2
Journal of Modern Oncology. 2010;12(3):4-5
		
				
					4-5
				
						
			
				
				
			
		Obzor konferentsii ekspertovv oblasti lekarstvennoy terapii rakapochki «Novye vozmozhnosti v terapiimetastaticheskogo raka pochki»
Journal of Modern Oncology. 2010;12(3):6-7
		
				
					6-7
				
						
			
				
				
			
		Gastrointestinal'nye stromal'nyeopukholi: obzor materialov ASCO 2010
Journal of Modern Oncology. 2010;12(3):7-11
		
				
					7-11
				
						
			
				
				
			
		Dobavlenie Zomety (zoledronata)k ad\"yuvantnoy endokrinoterapiiuvelichivaet vyzhivaemost' bol'nykhrannim retseptor-pozitivnym rakommolochnoy zhelezy
Journal of Modern Oncology. 2010;12(3):12-15
		
				
					12-15
				
						
			
				
				
			
		Spornye aspekty HER2-diagnostiki
Journal of Modern Oncology. 2010;12(3):15-19
		
				
					15-19
				
						
			
				
				
			
		Bevatsizumab v lechenii HER2-negativnogometastaticheskogo raka molochnoy zhelezy:sovremennye dannye ob effektivnostii bezopasnosti
Journal of Modern Oncology. 2010;12(3):19-23
		
				
					19-23
				
						
			
				
				
			
		Kapetsitabin v ad\"yuvantnoy terapiiraka molochnoy zhelezy
Journal of Modern Oncology. 2010;12(3):23-27
		
				
					23-27
				
						
			
				
				
			
		Vozmozhnosti khimioterapii rakamolochnoy zhelezy, rezistentnogok antratsiklinam i taksanam
Journal of Modern Oncology. 2010;12(3):28-33
		
				
					28-33
				
						
			
				
				
			
		Rol' lapatiniba v terapiimetastaticheskogo raka molochnoyzhelezy s ekspressiey gormonal'nykhretseptorov
Journal of Modern Oncology. 2010;12(3):34-38
		
				
					34-38
				
						
			
				
				
			
		Izuchenie gemtsitabina (Gemzar®)i tsisplatina v pervoy linii terapiirasprostranennogo raka yaichnika(issledovanie II fazy)
Journal of Modern Oncology. 2010;12(3):40-45
		
				
					40-45
				
						
			
				
				
			
		Ingibitory tirozinkinazy retseptoraepidermal'nogo faktora rosta:pokhozhie, no raznye? (Referat)
Journal of Modern Oncology. 2010;12(3):46-52
		
				
					46-52
				
						
			
				
				
			
		Opyt primeneniya Avastina (bevatsizumaba)v sochetanii s khimioterapiey v lecheniirasprostranennykh form nemelkokletochnogoraka legkogo v otdelenii torakal'noyonkologii
Journal of Modern Oncology. 2010;12(3):53-57
		
				
					53-57
				
						
			
				
				
			
		Vozmozhnosti targetnoy terapiipri lechenii neyroendokrinnykhopukholey zheludochno-kishechnogotrakta i podzheludochnoy zhelezy
Journal of Modern Oncology. 2010;12(3):57-61
		
				
					57-61
				
						
			
				
				
			
		Primenenie preparata sorafenibpri lechenii gepatotsellyulyarnoy kartsinomy(Obzor klinicheskikh i neinterventsionnykhissledovaniy: issledovanie GIDEON)
Journal of Modern Oncology. 2010;12(3):62-64
		
				
					62-64
				
						
			
				
				
			
		Panitumumab v terapii metastaticheskogokolorektal'nogo raka: dannye klinicheskikhissledovaniy, problema kozhnoy toksichnosti
Journal of Modern Oncology. 2010;12(3):65-70
		
				
					65-70
				
						
			
				
				
			
		Trabektedin v lekarstvennom lecheniisarkom myagkikh tkaney
Journal of Modern Oncology. 2010;12(3):71-74
		
				
					71-74
				
						
			
				
				
			
		Mesto konservativnoy terapiiv lechenii raka slizistoy obolochki shcheki
Journal of Modern Oncology. 2010;12(3):76-79
		
				
					76-79
				
						
			
				
				
			
		Nekhodzhkinskie limfomy kishechnika -pervichnoe ekstranodal'noe porazhenie
Journal of Modern Oncology. 2010;12(3):80-84
		
				
					80-84
				
						
			
				
				
			
		Mekhanizmy mobilizatsii gemopoeticheskikhpredshestvennikov granulotsitarnymkoloniestimuliruyushchim faktorom
Journal of Modern Oncology. 2010;12(3):84-88
		
				
					84-88
				
						
			
				
				
			
		Anemiya i sposoby ee korrektsiiu onkologicheskikh bol'nykh
Journal of Modern Oncology. 2010;12(3):89-93
		
				
					89-93
				
						
			
				
				
			
		Bezopasnost' ibandronovoy kislotypri dlitel'nom primenenii
Journal of Modern Oncology. 2010;12(3):93-94
		
				
					93-94
				
						
			
				
				
			
		Astenicheskie rasstroystva,assotsiirovannye s khimioterapieyzlokachestvennykh novoobrazovaniy(Obzor literatury)
Journal of Modern Oncology. 2010;12(3):96-101
		
				
					96-101
				
						
			
				
				
			
		Tekhnicheskie vozmozhnosti primeneniyakleevoy substantsii pri khirurgicheskikhvmeshatel'stvakh na organakh bryushnoypolosti
Journal of Modern Oncology. 2010;12(3):102-112
		
				
					102-112
				
						
			
				
				
			
		
					
						
						
				


